Demoralization clinical trials at UCSF

1 research study open to eligible people

Pragmatic Trial of Psilocybin Therapy in Palliative Care
open to eligible people ages 18 years and up
This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).
San Francisco, California and other locations

Last updated: March 3, 2025